Occupational Health Program: Appendix 3
Appendix 3: Vaccine Resources for Tier 1 BSAT
| Agent | Disease | Availability of vaccine | Type of vaccine | Source |
| Ebola virus | Ebola hemorrhagic fever | NAb | NA | NA |
| Marburg virus | Marburg hemorrhagic fever | NA | NA | NA |
| Variola major virus/ Variola minor virus | Smallpox | FDA licenseda | Live vaccine virus | CDCc |
| Yersinia pestis | Plague | NA | NA | NA |
| Botulinum neurotoxin/ Botulinum neurotoxin producing species of Clostridium | Botulism | NA | NA | NAd |
| Bacillus anthracis | Anthrax | FDA licenseda | Inactivated | Commercially available |
| Burkholderia mallei | Glanders | NA | NA | NA |
| Burkholderia pseudomallei | Melioidosis | NA | NA | NA |
Notes:
- IND – the vaccine is available under an Investigational New Drug protocol and is available for limited use.
- NA – not available.
- Smallpox Vaccine: CDC is the only source of vaccinia vaccine and VIG for civilians. Vaccine will be shipped to the responsible physician. Requests for vaccine and VIG, including the reason for the request, should be referred to:
Centers for Disease Control and Prevention
Drug Services, National Center for Infectious Diseases
Mailstop D-09
Atlanta, GA 30333
Telephone: (404) 639-3670
Facsimile: (404) 639-3717 - In 2011, CDC discontinued the distribution of Pentavalent (ABCDE) Botulinum Toxoid vaccine which was available under a CDC-sponsored FDA IND since 1965.
Page last reviewed: May 5, 2021, 02:55 PM
Content source: Division of Regulatory Science and Compliance